Ionis Pharmaceuticals
Price & Volume
Stats
See more52W Range | $40.26-$86.74 |
Market Cap | $6.8B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $874M |
Revenue Growth (YoY) | -40.7% |
Gross Profit (12 Mos) | -$60.6M |
Diluted EPS | -$3.30 |
News
See moreYahoo Finance • 8 days ago
NVS' Q3 Earnings Top Estimates on Strong Key Drug Sales, Revenues Miss
Yahoo Finance • 12 days ago
Ionis partner Roche announces new Phase 3 data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
Yahoo Finance • 15 days ago
Severe Hypertriglyceridemia Market Set for Growth During the Forecast Period (2026-2036) Following Approval of Ionis' TRYNGOLZA and Emergence of Novel Therapies | DelveInsight
Yahoo Finance • 19 days ago
Lilly, Pfizer, J&J among winners of EU drug recommendations this month
About
CEO | Dr. Brett P. Monia Ph.D. |
CFO | Ms. Elizabeth L. Hougen M.A., M.B.A., M.S. |
Address | 2855 Gazelle Court, Carlsbad, CA, United States, 92010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,480 |